{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T08:49:08Z","timestamp":1762159748882},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2001,5]]},"DOI":"10.1093\/humrep\/16.5.940","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T22:50:23Z","timestamp":1027723823000},"page":"940-944","source":"Crossref","is-referenced-by-count":29,"title":["Does obesity diminish the positive effect of oral contraceptive treatment on hyperandrogenism in women with polycystic ovarian syndrome?"],"prefix":"10.1093","volume":"16","author":[{"given":"D.","family":"Cibula","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Fanta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Sindelka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Zivny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2001,5]]},"reference":[{"key":"key\n\t\t\t\t20170410035731_ACIEN-ETAL-1999","doi-asserted-by":"crossref","unstructured":"Acie\u0301n, P., Quereda, F., Matali\u0301n, P. et al. (1999) Insulin, androgens, and obesity in women with and without polycystic ovary syndrome: a heterogenous group of disorders. Fertil. Steril., 72, 32\u201340.","DOI":"10.1016\/S0015-0282(99)00184-3"},{"key":"key\n\t\t\t\t20170410035731_ANDERSEN-ETAL-1995","doi-asserted-by":"crossref","unstructured":"Andersen, P., Seljeflot, I., Abdelnoor, M. et al. (1995) Increased insulin sensitivity and fibrinolytic capacity after dietary intervention in obese women with polycystic ovary syndrome. Metabolism, 44, 611\u2013616.","DOI":"10.1016\/0026-0495(95)90118-3"},{"key":"key\n\t\t\t\t20170410035731_ATIOMO-ETAL-2000","doi-asserted-by":"crossref","unstructured":"Atiomo, W.U., Fox, R., Condon, J.E. et al. (2000) Raised plasminogen activator inhibitor-1 (PAI-1) is not an independent risk factor in the polycystic ovary syndrome (PCOS). Clin. Endocrinol., 52, 487\u2013492.","DOI":"10.1046\/j.1365-2265.2000.00946.x"},{"key":"key\n\t\t\t\t20170410035731_BERGINK-ETAL-1981","doi-asserted-by":"crossref","unstructured":"Bergink, E.W., Holma, P. and Pyorala, T. (1981) Effects of oral contraceptive combinations containing levonorgestrel or desogestrel on serum proteins and androgen binding. Scand. J. Clin. Lab. Invest., 41, 663\u2013668.","DOI":"10.3109\/00365518109090512"},{"key":"key\n\t\t\t\t20170410035731_BURKE-AND-CUNLIFFE-1984","doi-asserted-by":"crossref","unstructured":"Burke, B.M. and Cunliffe, W.J. (1984) The assessment of acne vulgaris \u2013 the Leeds technique. Br. J. Dermatol., 111, 83\u201392.","DOI":"10.1111\/j.1365-2133.1984.tb04020.x"},{"key":"key\n\t\t\t\t20170410035731_BUYALOS-ETAL-1995","doi-asserted-by":"crossref","unstructured":"Buyalos, R.P., Pekonen, F., Halme, J. et al. (1995) The relationship between circulating androgens, obesity, and hyperinsulinemia on serum insulin-like growth factor binding protein-1 in the polycystic ovarian syndrome. Am. J. Obstet. Gynecol., 172, 932\u2013939.","DOI":"10.1016\/0002-9378(95)90024-1"},{"key":"key\n\t\t\t\t20170410035731_CIAMPELLI-ETAL-1999","doi-asserted-by":"crossref","unstructured":"Ciampelli, M., Fulghesu, A.M., Cucinelli, F. et al. (1999) Impact of insulin and body mass index on metabolic and endocrine variables in polycystic ovary syndrome. Metabolism, 48, 167\u2013172.","DOI":"10.1016\/S0026-0495(99)90028-8"},{"key":"key\n\t\t\t\t20170410035731_CIBULA-ETAL-2000","doi-asserted-by":"crossref","unstructured":"Cibula, D., Ci\u0301fkova, R., Fanta, M. et al. (2000) Increased risk of non-insulin dependent diabetes mellitus, arterial hypertension and coronary artery disease in perimenopausal women with a history of the polycystic ovary syndrome. Hum. Reprod., 15, 785\u2013789.","DOI":"10.1093\/humrep\/15.4.785"},{"key":"key\n\t\t\t\t20170410035731_COLLINS-1994","doi-asserted-by":"crossref","unstructured":"Collins, D.C. (1994) Sex hormone receptor binding, progestin selectivity, and the new oral contraceptives. Am. J. Obstet. Gynecol., 170, 1509\u20131513.","DOI":"10.1016\/S0002-9378(12)91808-6"},{"key":"key\n\t\t\t\t20170410035731_CONWAY-ETAL-1989","doi-asserted-by":"crossref","unstructured":"Conway, G.S., Honour, J.W. and Jacobs, H.S. (1989) Heterogeneity of the polycystic ovary syndrome: clinical, endocrine and ultrasound features in 556 patients. Clin. Endocrinol., 30, 459\u2013470.","DOI":"10.1111\/j.1365-2265.1989.tb00446.x"},{"key":"key\n\t\t\t\t20170410035731_DAHLGREN-ETAL-1992","doi-asserted-by":"crossref","unstructured":"Dahlgren, E., Johansson, S., Lindstedt, T. et al. (1992) Women with polycystic ovary syndrome wedge resected in 1956 to 1965: a long-term follow-up focusing on natural history and circulating hormones. Fertil. Steril., 57, 505\u2013513.","DOI":"10.1016\/S0015-0282(16)54892-4"},{"key":"key\n\t\t\t\t20170410035731_DAHLGREN-ETAL-1998","doi-asserted-by":"crossref","unstructured":"Dahlgren, E., Landin, K., Krotkiewski, M. et al. (1998) Effects of two antiandrogen treatments on hirsutism and insulin sensitivity in women with polycystic ovary syndrome. Hum. Reprod., 13, 2706\u20132711.","DOI":"10.1093\/humrep\/13.10.2706"},{"key":"key\n\t\t\t\t20170410035731_DUNAIF-ETAL-1987","doi-asserted-by":"crossref","unstructured":"Dunaif, A., Graf, M., Mandeli, J. et al. (1987) Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance and\/or hyperinsulinemia. J. Clin. Endocrinol. Metab., 65, 499\u2013507.","DOI":"10.1210\/jcem-65-3-499"},{"key":"key\n\t\t\t\t20170410035731_DUNAIF-ETAL-1988","doi-asserted-by":"crossref","unstructured":"Dunaif, A., Mandeli, J., Fluhr, H. and Dobyansky, A. (1988) The impact of obesity and chronic hyperinsulinemia on gonadotropin release and gonadal steroid secretion in the polycystic ovary syndrome. J. Clin. Endocrinol. Metab., 66, 131\u2013139.","DOI":"10.1210\/jcem-66-1-131"},{"key":"key\n\t\t\t\t20170410035731_DUNAIF-ETAL-1989","doi-asserted-by":"crossref","unstructured":"Dunaif, A., Segal, K.R., Futterweit, W. and Dobrjansky, A. (1989) Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes, 38, 1165\u20131174.","DOI":"10.2337\/diab.38.9.1165"},{"key":"key\n\t\t\t\t20170410035731_EHRMANN-ETAL-1999","doi-asserted-by":"crossref","unstructured":"Ehrmann, D.A., Barnes, R.B., Rosenfield, R.L. et al. (1999) Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care, 22, 141\u2013146.","DOI":"10.2337\/diacare.22.1.141"},{"key":"key\n\t\t\t\t20170410035731_FALSETTI-AND-GALBIGNANI-1990","doi-asserted-by":"crossref","unstructured":"Falsetti, L. and Galbignani, E. (1990) Long-term treatment with the combination ethinylestradiol and cyproterone acetate in polycystic ovary syndrome. Contraception, 42, 611\u2013619.","DOI":"10.1016\/0010-7824(90)90002-D"},{"key":"key\n\t\t\t\t20170410035731_FALSETTI-AND-PASINETTI-1995","doi-asserted-by":"crossref","unstructured":"Falsetti, L. and Pasinetti, E. (1995) Effects of long-term administration of an oral contraceptive containing ethinylestradiol and cyproterone acetate on lipid metabolism in women with polycystic ovary syndrome. Acta Obstet. Gynecol. Scand., 74, 56\u201360.","DOI":"10.3109\/00016349509009945"},{"key":"key\n\t\t\t\t20170410035731_FERRIMAN-AND-GALLWEY-1961","doi-asserted-by":"crossref","unstructured":"Ferriman, D. and Gallwey, J.D. (1961) Clinical assessment of body hair growth in women. J. Clin. Endocrinol. Metab., 21, 1440\u20131447.","DOI":"10.1210\/jcem-21-11-1440"},{"key":"key\n\t\t\t\t20170410035731_FRIEDEWALD-ETAL-1972","unstructured":"Friedewald, W.T., Levy, R.I. and Frederickson, D.S. (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of preparative ultracentrifuge. Clin. Chem., 18, 499\u2013502."},{"key":"key\n\t\t\t\t20170410035731_GEVERS-LEUVEN-ETAL-1990","doi-asserted-by":"crossref","unstructured":"Gevers Leuven, J.A., Dersjant-Roorda, M.C., Helmerhorst, F.M. et al. (1990) Estrogenic effect of gestodene- or desogestrel-containing oral contraceptives on lipoprotein metabolism. Am. J. Obstet. Gynecol., 163, 358\u2013362.","DOI":"10.1016\/0002-9378(90)90582-R"},{"key":"key\n\t\t\t\t20170410035731_GJONNAESS-1994","doi-asserted-by":"crossref","unstructured":"Gjonnaess, H. (1994) Ovarian electrocautery in the treatment of women with polycystic ovary syndrome (PCOS). Factors affecting the results. Acta Obstet. Gynecol. Scand., 73, 407\u2013412.","DOI":"10.3109\/00016349409006253"},{"key":"key\n\t\t\t\t20170410035731_GJONNAESS-1999","doi-asserted-by":"crossref","unstructured":"Gjonnaess, H. (1999) Comparison of ovarian electrocautery and oral contraceptives in the treatment of hyperandrogenism in women with polycystic ovary syndrome. Acta Obstet. Gynecol. Scand., 78, 530\u2013533.","DOI":"10.1080\/j.1600-0412.1999.780610.x"},{"key":"key\n\t\t\t\t20170410035731_GLASS-ETAL-1981","doi-asserted-by":"crossref","unstructured":"Glass, A.R., Burman, K.D., Dahms, W.T. and Boehm, T.M. (1981) Endocrine function in human obesity. Metabolism, 30, 89\u2013104.","DOI":"10.1016\/0026-0495(81)90224-9"},{"key":"key\n\t\t\t\t20170410035731_GOLLAND-ETAL-1990","doi-asserted-by":"crossref","unstructured":"Golland, I.M., Williams, V.C.A., Shalet, S.M. et al. (1990) Glucagon in women with polycystic ovary syndrome (PCO): relationship to abnormalities of insulin and androgens. Clin. Endocrinol., 33, 645\u2013651.","DOI":"10.1111\/j.1365-2265.1990.tb03903.x"},{"key":"key\n\t\t\t\t20170410035731_GRAF-ETAL-1990","doi-asserted-by":"crossref","unstructured":"Graf, M.J., Richards, C.J., Brown, V. et al. (1990) The independent effect of hyperandrogenaemia, hyperinsulinaemia, and obesity on lipid and lipoprotein profiles in women. Clin. Endocrinol., 33, 119\u2013131.","DOI":"10.1111\/j.1365-2265.1990.tb00472.x"},{"key":"key\n\t\t\t\t20170410035731_HAMMOND-ETAL-1984","doi-asserted-by":"crossref","unstructured":"Hammond, G.L., Langley, M.S., Robinson, P.A. et al. (1984) Serum steroid binding protein concentrations, distribution of progestogens, and bioavailability of testosterone during treatment with contraceptives containing desogestrel or levonorgestrel. Fertil. Steril., 42, 44\u201351.","DOI":"10.1016\/S0015-0282(16)47956-2"},{"key":"key\n\t\t\t\t20170410035731_HOLTE-ETAL-1995","unstructured":"Holte, J., Bergh, T., Berne, C. et al. (1995) Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab., 80, 2586\u20132593."},{"key":"key\n\t\t\t\t20170410035731_KIRSCHNER-ETAL-1983","doi-asserted-by":"crossref","unstructured":"Kirschner, M.A., Samojlik, E. and Silber, D. (1983) A comparison of androgen production and clearance in hirsute and obese women. J. Steroid Biochem., 19, 607\u2013614.","DOI":"10.1016\/0022-4731(83)90225-X"},{"key":"key\n\t\t\t\t20170410035731_KUHL-ETAL-1990","doi-asserted-by":"crossref","unstructured":"Kuhl, H., Marz, W., Jung-Hoffman, C. et al. (1990) Time-dependent alterations in lipid metabolism during treatment with low-dose oral contraceptives. Am. J. Obstet. Gynecol., 163, 363\u2013369.","DOI":"10.1016\/0002-9378(90)90583-S"},{"key":"key\n\t\t\t\t20170410035731_KURTZ-ETAL-1987","doi-asserted-by":"crossref","unstructured":"Kurtz, B.R., Givens, J.R., Komindr, S. et al. (1987) Maintenance of normal circulating levels of delta 4-androstenedione and dehydroepiandrosterone in simple obesity despite increased metabolic clearance rates: evidence for a servo-control mechanism. J. Clin. Endocrinol. Metab., 64, 1261\u20131267.","DOI":"10.1210\/jcem-64-6-1261"},{"key":"key\n\t\t\t\t20170410035731_LEGRO-ETAL-1999","doi-asserted-by":"crossref","unstructured":"Legro, R.S., Kunselman, A.R., Dodson, W.C. and Dunaif, A. (1999) Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J. Clin. Endocrinol. Metab., 84, 165\u2013169.","DOI":"10.1210\/jc.84.1.165"},{"key":"key\n\t\t\t\t20170410035731_LUCKY-ETAL-1997","doi-asserted-by":"crossref","unstructured":"Lucky, A.W., Henderson, T.A., Olson, W.H. et al. (1997) Effectiveness of norgestimate and ethinyl-estradiol in treating moderate acne vulgaris. J. Am. Acad. Dermatol., 37, 746\u2013754.","DOI":"10.1016\/S0190-9622(97)70112-9"},{"key":"key\n\t\t\t\t20170410035731_MANGO-ETAL-1996","doi-asserted-by":"crossref","unstructured":"Mango, D., Ricci, S., Manna, P. et al. (1996) Clinical and hormonal effects of ethinylestradiol combined with gestodene and desogestrel in young women with acne vulgaris. Contraception, 53, 163\u2013170.","DOI":"10.1016\/0010-7824(96)00005-4"},{"key":"key\n\t\t\t\t20170410035731_MORALES-ETAL-1996","unstructured":"Morales, A.J., Laughlin, G.A., Bu\u0308tzow, T. et al. (1996) Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features. J. Clin. Endocrinol. Metab., 81, 2854\u20132864."},{"key":"key\n\t\t\t\t20170410035731_PALATSI-ETAL-1984","unstructured":"Palatsi, R., Hirvensalo, E., Liukko, P. et al. (1984) Serum total and unbound testosterone and sex hormone binding globulin in female acne patients treated with two different oral contraceptives. Acta Derm. Venereol., 64, 517\u2013523."},{"key":"key\n\t\t\t\t20170410035731_PASQUALI-AND-CASIMIRRI-1993","doi-asserted-by":"crossref","unstructured":"Pasquali, R. and Casimirri, F. (1993) The impact of obesity on hyperandrogenism and polycystic ovary syndrome in premenopausal women. Clin. Endocrinol., 39, 1\u201316.","DOI":"10.1111\/j.1365-2265.1993.tb01744.x"},{"key":"key\n\t\t\t\t20170410035731_PASQUALI-ETAL-1987","doi-asserted-by":"crossref","unstructured":"Pasquali, R., Antenucci, D., Malchionda, N. et al. (1987) Sex hormones in obese premenopausal women and their relationship to body fat and distribution, B cell function and diet composition. J. Endocrinol. Invest., 10, 345\u2013350.","DOI":"10.1007\/BF03348145"},{"key":"key\n\t\t\t\t20170410035731_PASQUALI-ETAL-1989","doi-asserted-by":"crossref","unstructured":"Pasquali, R., Antenucci, D., Casimirri, F. et al. (1989) Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss. J. Clin. Endocrinol. Metab., 68, 173\u2013179.","DOI":"10.1210\/jcem-68-1-173"},{"key":"key\n\t\t\t\t20170410035731_PETERSEN-ETAL-1988","doi-asserted-by":"crossref","unstructured":"Petersen, K.B., Skouby, S.O., Dreisler, A. et al. (1988) Comparative trial of the effects on glucose tolerance and lipoprotein metabolism of two new oral contraceptives containing gestodene and desogestrel. Acta Obstet. Gynecol. Scand., 67, 37\u201341.","DOI":"10.3109\/00016348809004165"},{"key":"key\n\t\t\t\t20170410035731_PURIFOY-ETAL-1981","doi-asserted-by":"crossref","unstructured":"Purifoy, F.E., Koopmans, L.H., Tatum, R.W. and Mayes, D.M. (1981) Serum androgen and sex hormone-binding globulin in obese Pima Indian females. Am. J. Phys. Anthropol., 55, 491\u2013496.","DOI":"10.1002\/ajpa.1330550410"},{"key":"key\n\t\t\t\t20170410035731_REDMOND-ETAL-1997","doi-asserted-by":"crossref","unstructured":"Redmond, G.P., Olson, W.H., Lippman, J.S. et al. (1997) Norgestimate and ethinyl estradiol in the treatment of acne vulgaris: a randomized, placebo-controlled study. Obstet. Gynecol., 89, 615\u2013622.","DOI":"10.1016\/S0029-7844(97)00059-8"},{"key":"key\n\t\t\t\t20170410035731_SPEROFF-AND-DECHERNEY-1993","unstructured":"Speroff, L. and DeCherney, L. (1993) Evaluation of a new generation of oral contraceptives. Obstet. Gynecol., 81, 1034\u20131047."},{"key":"key\n\t\t\t\t20170410035731_VAN-DER-VANGE-ETAL-1990","doi-asserted-by":"crossref","unstructured":"van der Vange, J., Blankenstein, M.A., Kloosterboer, H.J. et al. (1990) Effects of seven low-dose combined oral contraceptives on sex hormone binding globulin, corticosteroid binding globulin, total and free testosterone. Contraception, 41, 345\u2013352.","DOI":"10.1016\/0010-7824(90)90034-S"},{"key":"key\n\t\t\t\t20170410035731_WILD-ETAL-1991","doi-asserted-by":"crossref","unstructured":"Wild, R.A., Demers, L.M., Applebaum-Bowden, D. and Lenker, R. (1991) Hirsutism: metabolic effects of two commonly used oral contraceptives and spironolactone. Contraception, 44, 113\u2013124.","DOI":"10.1016\/0010-7824(91)90112-S"},{"key":"key\n\t\t\t\t20170410035731_YEN-1980","doi-asserted-by":"crossref","unstructured":"Yen, S.S.C. (1980) The polycystic ovary syndrome. Clin. Endocrinol., 12, 177\u2013183.","DOI":"10.1111\/j.1365-2265.1980.tb02132.x"}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","deposited":{"date-parts":[[2017,6,15]],"date-time":"2017-06-15T07:14:26Z","timestamp":1497510866000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/humrep\/article-lookup\/doi\/10.1093\/humrep\/16.5.940"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,5]]},"references-count":46,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2001,5]]},"published-print":{"date-parts":[[2001,5]]}},"URL":"https:\/\/doi.org\/10.1093\/humrep\/16.5.940","relation":{},"ISSN":["1460-2350","0268-1161"],"issn-type":[{"value":"1460-2350","type":"electronic"},{"value":"0268-1161","type":"print"}],"subject":[],"published":{"date-parts":[[2001,5]]}}}